According to ImmunoGen 's latest financial reports the company's total assets are โน70.54 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | โน28.87 B | -26.22% |
2021-12-31 | โน39.13 B | 50.7% |
2020-12-31 | โน25.96 B | 54.78% |
2019-12-31 | โน16.77 B | -18.77% |
2018-12-31 | โน20.65 B | 9.77% |
2017-12-31 | โน18.81 B | |
2016-06-30 | โน18.82 B | -4.16% |
2015-06-30 | โน19.64 B | 97.91% |
2014-06-30 | โน9.92 B | -21.95% |
2013-06-30 | โน12.71 B | 27.05% |
2012-06-30 | โน10.00 B | 2.75% |
2011-06-30 | โน9.74 B | 53.01% |
2010-06-30 | โน6.36 B | 32.26% |
2009-06-30 | โน4.81 B | 34.79% |
2008-06-30 | โน3.57 B | 9.56% |
2007-06-30 | โน3.25 B | -24.4% |
2006-06-30 | โน4.31 B | -9.92% |
2005-06-30 | โน4.78 B | -14.94% |
2004-06-30 | โน5.62 B | 2.85% |
2003-06-30 | โน5.47 B | -26.43% |
2002-06-30 | โน7.43 B | -0.61% |
2001-06-30 | โน7.48 B |